药政信息是制药行业必须关注的内容，它包括政策法规、技术指南、制药科学与技术以及行业信息与动态等。如何及时全面的获得药政信息至关重要，总结出如下网站供大家参考，方便大家查询。
https://www.fda.gov/about-fdahttps://www.fda.gov/drugs/guidance-compliance-regulatory-informationhttps://www.fda.gov/regulatory-information/search-fda-guidance-documents在FDA官网检索 Questions and Answers on Current Good Manufacturing Practiceshttps://www.fda.gov/drugs/drug-master-files-dmfs/list-drug-master-files-dmfshttps://www.fda.gov/drugs/drug-master-files-dmfs/types-drug-master-files-dmfshttps://www.accessdata.fda.gov/scripts/cder/iig/index.cfmhttps://www.accessdata.fda.gov/scripts/cder/dissolution/index.cfmhttps://www.accessdata.fda.gov/scripts/cder/ob/index.cfmhttps://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-lettershttps://purplebooksearch.fda.gov/https://www.accessdata.fda.gov/scripts/cder/daf/index.cfmhttps://www.accessdata.fda.gov/scripts/cder/drls/default.cfmhttps://www.ecfr.gov/cgi-bin/ECFR?page=browsehttps://www.accessdata.fda.gov/scripts/cder/cliil/index.cfmhttp://www.freepatentsonline.com/https://www.ema.europa.eu/en/human-regulatory/research-development/scientific-advice-protocol-assistanceEMA scientific guideline检索：https://www.ema.europa.eu/en/human-regulatory/research-development/scientific-guidelineshttps://ec.europa.eu/health/documents/eudralex/vol-4_enhttps://www.ema.europa.eu/en/human-regulatory/research-development/compliance/good-manufacturing-practice/guidance-good-manufacturing-practice-good-distribution-practice-questions-answershttps://www.ema.europa.eu/en/medicines/download-medicine-data#european-public-assessment-reports-(epar)-sectionhttps://www.ema.europa.eu/en/medicines/field_ema_web_categories%253Aname_field/Human/ema_group_types/ema_withdrawn_applicationshttps://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/good-pharmacovigilance-practiceshttps://www.ema.europa.eu/en/human-regulatory/research-development/pharmacovigilance/eudravigilancehttps://www.edqm.eu/en/certification-policy-documents-guidelineshttps://www.edqm.eu/en/quality-management-qm-documentshttps://www.edqm.eu/en/food-contact-materialshttps://extranet.edqm.eu/publications/recherches_CEP.shtmlhttps://faq.edqm.eu/display/FAQS/EDQM+Reference+Standardshttps://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/generic-medicines/generic-hybrid-applicationshttps://www.hma.eu/mriproductindex.htmlhttps://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agencyhttps://products.mhra.gov.uk/https://www.gov.uk/search/guidance-and-regulationhttps://www.gov.uk/guidance/good-manufacturing-practice-and-good-distribution-practicehttps://www.who.int/medicines/regulation/en/https://www.who.int/bloodproducts/gmp/en/https://extranet.who.int/prequal/content/who-technical-report-serieshttps://www.who.int/news-room/fact-sheets/detail/prequalification-of-medicines-by-whohttps://extranet.who.int/prequal/content/prequalified-lists/medicineshttps://extranet.who.int/prequal/content/active-pharmaceutical-ingredients-0https://extranet.who.int/prequal/content/medicines-quality-control-laboratories-listhttps://extranet.who.int/prequal/content/prequalification-reportshttps://extranet.who.int/prequal/WHOPAR/ma044https://extranet.who.int/prequal/content/who-medicines-prequalification-guidancehttps://extranet.who.int/prequal/content/market-informationhttps://www.who.int/ipcs/network/en/https://picscheme.org/en/publicationshttps://picscheme.org/ey77n/membershttps://www.ich.org/page/ich-guidelineshttps://www.apic.cefic.org/publications.htmlhttps://www.nifdc.org.cn/nifdc/
声明：药研对本文观点保持中立，文章仅供交流学习使用，版权归原作者所有。
